101 related articles for article (PubMed ID: 3135811)
1. Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Biochem Pharmacol; 1988 Sep; 37(17):3277-83. PubMed ID: 3135811
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Neurosci Lett; 1987 May; 76(3):335-8. PubMed ID: 3108730
[TBL] [Abstract][Full Text] [Related]
3. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Jan; 133(3):319-28. PubMed ID: 3556394
[TBL] [Abstract][Full Text] [Related]
5. Effects of metaphit on phencyclidine and serotonin2 receptors.
Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats.
Yamaguchi K; Nabeshima T; Ishikawa K; Yoshida S; Kameyama T
Neuropharmacology; 1987 Oct; 26(10):1489-97. PubMed ID: 2446188
[TBL] [Abstract][Full Text] [Related]
7. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine-induced head-weaving observed in mice after ritanserin treatment.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Jul; 139(2):171-8. PubMed ID: 2888667
[TBL] [Abstract][Full Text] [Related]
9. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
10. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
[TBL] [Abstract][Full Text] [Related]
11. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
13. Effects of phencyclidine metabolites on serotonin uptake in rat brain.
Hori T; Suzuki T; Baba A; Abe S; Yamamoto T; Moroji T; Shiraishi H
Neurosci Lett; 1996 May; 209(3):153-6. PubMed ID: 8736633
[TBL] [Abstract][Full Text] [Related]
14. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
15. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
Frenken M; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
17. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
18. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
[TBL] [Abstract][Full Text] [Related]
19. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
20. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
